Fresenius SE & Co saw the highest growth of 1.59% in patent filings in May and 2.08% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.24% and grants by 2.08%. GlobalData’s DataBook provides a comprehensive analysis of Fresenius SE & Co’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Fresenius SE & Co has been focused on protecting inventions in United States(US) with 32 publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 37% filings and 41% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where Fresenius SE & Co is filings its patents. Among the top granted patent authorities, Fresenius SE & Co has 41% of its grants in United States(US), 26% in European Patent Office(EPO) and 11% in China(CN).

Taiwan Mitochondrion Applied Technology and Terumo could be the strongest competitors for Fresenius SE & Co

In terms of grant share, Fresenius SE & Co stands first among its competitors followed by Taiwan Mitochondrion Applied Technology and Terumo.

Patents related to healthtech and remote patient monitoring lead Fresenius SE & Co's portfolio

Fresenius SE & Co has the highest number of patents in healthtech followed by, remote patient monitoring and smart hospitals. For healthtech, nearly 22% of patents were filed and 13% of patents were granted in Q2 2024.

Drug delivery devices related patents lead Fresenius SE & Co portfolio followed by healthcare it, and other remote patient monitoring

Fresenius SE & Co has highest number of patents in drug delivery devices followed by healthcare it, other remote patient monitoring, nephrology and urology devices, and packaging. For drug delivery devices, nearly 11% of patents were filed and 8% of patents were granted in Q2 2024.

For comprehensive analysis of Fresenius SE & Co's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.